News

14 January 2019
  • Medicina Regenerativa
  • Neurociències

Defective glial cells can push neurons toward Parkinson's disease

A team of scientists led by Prof. Antonella Consiglio from the IDIBELL and the University of Barcelona (UB), and Prof.

09 January 2019
  • Neurociències

IDIBELL researchers identify a new leukodystrophy in children and its potential cure

The Neurometabolic Diseases research team at IDIBELL and CIBER of Rare Diseases (CIBERER), led by ICREA Professor Aurora Pujol, has uncovered a novel disease of children affecting the brain white matter –the myelin sheath-, leading to severe incapacity and death in some case

 

19 December 2018
  • Càncer
  • Medicina Regenerativa
  • Neurociències
  • Medicina Translacional

¡idiBELL Christmas and happy 2019!

Christmas card from Zoe López, a student of Institut Bellvitge

13 December 2018
  • Medicina Translacional

IDIBELL and Bellvitge University Hospital develop a new treatment to fight against hospital infections

Bacteria resistance to antibiotics is one of the most pressing issues in public health worldwide. The continuous growth of infections caused by these microbes can cause more than 10 million deaths per year in the year 2050, as it happened in the preantibiotic era.

12 December 2018
  • Neurociències

An intellectually active lifestyle protects against neurodegeneration in people with Huntington's disease

Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute (IDIBELL) and the University of Barcelona (UB), in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegene